Longmang Baili released the pledge announcement - the shareholder pledged 17mn
On October 29, longmang Baili issued a notice on the pledge of the company's shareholders' shares. Up to now, Yuxin xylose holds 38668613 shares of the company, accounting for 1.90% of the total share capital of the company. After the pledge of some shares, Yuxin xylose holds 17112000 shares of the company, accounting for 44.25% of the shares of Yuxin xylose and 0.84% of the total share capital of the company.
You May Interested In
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
When SWIFT Goes On-Chain: A New 24/7 Order for Cross-Border Payments
-
“The 40-Year Ethylene Giant Collapses”: ExxonMobil’s Premature Shutdown Is Not Just Scotland’s Tragedy—It’s the Twilight Elegy of European Industrial Civilization
-
Merck Wins Approval for the World’s First Oral PCSK9 Drug, with Potential Annual Sales of $5 Billion
-
Private Equity Firm Acquires Lyons Magnus for About $1 Billion as Beverage and Nutrition Ingredients Consolidate
-
“Zero Tariff Is Not a Get-Out-of-Jail-Free Card”: Hainan’s Full Customs Closure—Boon or Trap for the Chemical Industry?
-
“Did They Just Buy a Money Printer for ¥288 Million?”: Yip’s Chemical’s Bold Bet on Green Tech—Is This a Genuine Transformation or Just Another Story for the Stock Market?
-
Agrochemical Markets at a Crossroads: Winter Stockpiling Begins Amid Cost Pressures and Fragmented Demand
-
Afidopyropen: The Silent Assassin of Sap-Sucking Pests—Promise, Pitfalls, and the Path to Sustainable Deployment
-
Jiangsu Fengshan Biochem Gears Up for Strategic Expansion in Selective Herbicide Intermediates and Active Ingredients
-
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
Recommend Reading
-
![FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma]()
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
![Continental Tires Out, Franchise Power In: Continental Group Spins Off French Retail Arm to ASC in Strategic Pivot]()
Continental Tires Out, Franchise Power In: Continental Group Spins Off French Retail Arm to ASC in Strategic Pivot
-
![China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge]()
China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge
-
![Rhine Drought Disrupts German Chemical Logistics, Raising Supply Risks for BASF, Covestro and Evonik]()
Rhine Drought Disrupts German Chemical Logistics, Raising Supply Risks for BASF, Covestro and Evonik
-
![China’s PE, PP and PVC Exports Rise as Stockpile Releases Reshape Global Supply]()
China’s PE, PP and PVC Exports Rise as Stockpile Releases Reshape Global Supply
-
![Chinese Asphalt Market Sees Limited Transactions Before the Festival, May Rise Moderately After the Festival]()
Chinese Asphalt Market Sees Limited Transactions Before the Festival, May Rise Moderately After the Festival
-
![Cyclohexane Market Supply and Demand Balance, Prices Remain Stable]()
Cyclohexane Market Supply and Demand Balance, Prices Remain Stable
-
![Methanol Market Partially Rises]()
Methanol Market Partially Rises
-
![Premium Global Chemical Sourcing Requests (7 - 11 Feb, 2026)]()
Premium Global Chemical Sourcing Requests (7 - 11 Feb, 2026)
-
![关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI]()
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
